E-mail: info@lusopalex.com | Tlf: (+351) 214 344 740
Site logo
Sticky header logo
Mobile logo
  • Our DNA
  • Our Solutions
    • in vitro Diagnostics
    • Life Sciencies
    • Veterinary
    • Equipment
  • News
  • Events
  • EN
  • PT

Author Archives: buzzhost

News TECO ®Fungi Line
4 February, 2022in News 0 Comments 0 Likes

TECO ®Fungi Line

by buzzhost
News BÜHLMANN fCAL® turbo – Automated Immunoturbidimetric Trial for Fecal Calprotectin dosage
9 October, 2019in News 0 Comments 0 Likes

BÜHLMANN fCAL® turbo – Automated Immunoturbidimetric Trial for Fecal Calprotectin dosage

Fecal calprotectin can be dosed with BÜHLMANN fCAL® turbo kit on different clinical chemistry platforms, allowing consolidation and improvement of lab workflow. This application allows random sample access, a quick

by buzzhost
News Theradiag Lisa Tracker: Monitoring of Biological Drugs
9 October, 2019in News 0 Comments 0 Likes

Theradiag Lisa Tracker: Monitoring of Biological Drugs

ANTICIPATION, OPTIMIZATION AND ORIENTATION in the treatment with biological drugs of patients with cancer or chronic inflammatory diseases. Currently, about 70% of new drugs are biological and it seems to be

by buzzhost
News New partner in Immunoallergology – Macro Array Diagnostics GmbH
9 October, 2019in News 0 Comments 0 Likes

New partner in Immunoallergology – Macro Array Diagnostics GmbH

We are pleased to inform you that Macro Array Diagnostics GmbH is our latest partner in Immunology. Allergy Explorer, ALEX, is the first multiplex in vitro allergy test with the widest

by buzzhost
logo
  • in vitro Diagnostics
  • Life Sciencies
  • Veterinary
  • Equipment
© Copyright 2025 All Rights Reserved
div#stuning-header .dfd-stuning-header-bg-container {background-image: url(https://arium.pt/wp-content/uploads/2019/03/arium-agenda_layer.png);background-color: #822433;background-size: cover;background-position: center center;background-attachment: scroll;background-repeat: no-repeat;}#stuning-header div.page-title-inner {min-height: 300px;}#main-content .dfd-content-wrap {margin: -10px;} #main-content .dfd-content-wrap > article {padding: 10px;}@media only screen and (min-width: 1101px) {#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars {padding: 0 20px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child {border-top: 20px solid transparent; border-bottom: 10px solid transparent;}#layout.dfd-portfolio-loop > .row.full-width #right-sidebar,#layout.dfd-gallery-loop > .row.full-width #right-sidebar {padding-top: 10px;padding-bottom: 10px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars .sort-panel,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars .sort-panel {margin-left: -20px;margin-right: -20px;}}#layout .dfd-content-wrap.layout-side-image,#layout > .row.full-width .dfd-content-wrap.layout-side-image {margin-left: 0;margin-right: 0;}